Cargando…
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism
Understanding pharmacokinetic (PK)-pharmacodynamic (PD) relationships is essential in translational research. Existing PK-PD models for combination therapy lack consideration of quantitative contributions from individual drugs, whereas interaction factor is always assigned arbitrarily to one drug an...
Autores principales: | Choi, Young Hee, Zhang, Chao, Liu, Zhenzhen, Tu, Mei-Juan, Yu, Ai-Xi, Yu, Ai-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140393/ https://www.ncbi.nlm.nih.gov/pubmed/33712506 http://dx.doi.org/10.1124/jpet.121.000584 |
Ejemplares similares
-
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
por: Franco, Antonietta, et al.
Publicado: (2022) -
Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies
por: Ferreira, W.A., et al.
Publicado: (2020) -
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain
por: Kostich, Walter, et al.
Publicado: (2016) -
The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers
por: Soares, Holly D., et al.
Publicado: (2016) -
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects
por: Toyn, Jeremy H., et al.
Publicado: (2016)